About Tekla Healthcare Investors (NYSE:HQH)
Tekla Healthcare Investors is a non-diversified closed-end healthcare fund. The Fund's investment objective is to seek long-term capital appreciation by investing primarily in securities of healthcare companies. It seeks to provide regular distribution of realized capital gains. It may invest up to 20% of its net assets in securities of foreign issuers, located primarily in Western Europe, Canada and Japan, and securities of United States issuers that are traded in foreign markets. It invests in healthcare industries and is focused on the smaller, emerging companies, investing a maximum of 40% of the Fund's assets in restricted securities of both public and private companies. The Fund invests in subsectors, such as biotechnology, pharmaceuticals, healthcare equipment, healthcare supplies, life science tools and services, healthcare distributors, managed healthcare, healthcare technology, and healthcare facilities. Tekla Capital Management LLC is the advisor of the Fund.
Industry, Sector and Symbol
Industry INVESTMENT FUNDS
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
Tekla Healthcare Investors (NYSE:HQH) Frequently Asked Questions
What is Tekla Healthcare Investors' stock symbol?
Tekla Healthcare Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "HQH."
How often does Tekla Healthcare Investors pay dividends? What is the dividend yield for Tekla Healthcare Investors?
Tekla Healthcare Investors announced a quarterly dividend on Friday, February 16th. Investors of record on Wednesday, February 28th will be paid a dividend of $0.48 per share on Thursday, March 29th. This represents a $1.92 dividend on an annualized basis and a yield of 8.70%. The ex-dividend date is Tuesday, February 27th. View Tekla Healthcare Investors' Dividend History.
Who are some of Tekla Healthcare Investors' key competitors?
Some companies that are related to Tekla Healthcare Investors include Hamilton Lane Advisors (HLNE), Horace Mann Educators (HMN), BancFirst (BANF), Nationstar Mortgage (NSM), First Financial Bank (FFBC), Berkshire Hills Bancorp (BHLB), Pra Group (PRAA), Capitol Federal Financial (CFFN), Provident Financial Services (PFS), Northwest Bancshares (NWBI), Ares Management (ARES), FS Investment (FSIC), FBL Financial Group (FFG), Alexander & Baldwin (ALEX), OM Asset Management (OMAM), Redfin (RDFN), Navigators Group (NAVG) and Fanhua (FANH).
Who are Tekla Healthcare Investors' key executives?
Tekla Healthcare Investors' management team includes the folowing people:
- Oleg M. Pohotsky, Independent Chairman of the Board of Trustees (Age 70)
- Daniel R. Omstead Ph.D., President, Trustee (Age 64)
- Laura Woodward CPA, Chief Compliance Officer, Treasurer, Secretary (Age 49)
- Michael W. Bonney, Independent Trustee (Age 59)
- Rakesh K. Jain Ph.D., Independent Trustee (Age 67)
- William S. Reardon CPA, Independent Trustee (Age 71)
- Uwe E. Reinhardt Ph.D., Independent Trustee (Age 80)
- Lucinda H. Stebbins CPA, Independent Trustee (Age 72)
Has Tekla Healthcare Investors been receiving favorable news coverage?
News coverage about HQH stock has trended somewhat negative on Thursday, Accern reports. Accern identifies negative and positive news coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Tekla Healthcare Investors earned a news sentiment score of -0.03 on Accern's scale. They also assigned media headlines about the financial services provider an impact score of 46.22 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.
Who are Tekla Healthcare Investors' major shareholders?
Tekla Healthcare Investors' stock is owned by many different of retail and institutional investors. Top institutional shareholders include Needham Investment Management LLC (0.97%), Raymond James & Associates (0.78%), Wells Fargo & Company MN (0.68%), City of London Investment Management Co. Ltd. (0.64%), Wolverine Asset Management LLC (0.53%) and Goldman Sachs Group Inc. (0.24%). View Institutional Ownership Trends for Tekla Healthcare Investors.
Which major investors are selling Tekla Healthcare Investors stock?
Which major investors are buying Tekla Healthcare Investors stock?
HQH stock was acquired by a variety of institutional investors in the last quarter, including City of London Investment Management Co. Ltd., Wolverine Asset Management LLC, Raymond James & Associates, Raymond James Financial Services Advisors Inc., Thomas J. Herzfeld Advisors Inc., Goldman Sachs Group Inc., First Trust Advisors LP and NINE MASTS CAPITAL Ltd. View Insider Buying and Selling for Tekla Healthcare Investors.
How do I buy shares of Tekla Healthcare Investors?
Shares of HQH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Tekla Healthcare Investors' stock price today?
One share of HQH stock can currently be purchased for approximately $22.07.
How big of a company is Tekla Healthcare Investors?
Tekla Healthcare Investors has a market capitalization of $908.50 million.
How can I contact Tekla Healthcare Investors?
Tekla Healthcare Investors' mailing address is 2 LIBERTY SQUARE 9TH FLOOR, BOSTON MA, 02109. The financial services provider can be reached via phone at 617-772-8500 or via email at [email protected]
MarketBeat Community Rating for Tekla Healthcare Investors (HQH)MarketBeat's community ratings are surveys of what our community members think about Tekla Healthcare Investors and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Tekla Healthcare Investors (NYSE:HQH) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Earnings History for Tekla Healthcare Investors (NYSE:HQH)
No earnings announcements for this company have been tracked by MarketBeat.com
Tekla Healthcare Investors (NYSE:HQH) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Tekla Healthcare Investors (NYSE:HQH) Dividend Information
|Dividend Growth:||-3.70% (3 Year Average)|
Tekla Healthcare Investors (NYSE:HQH) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Tekla Healthcare Investors (NYSE HQH) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 1.00%
Institutional Ownership Percentage: 19.28%
Tekla Healthcare Investors (NYSE HQH) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|1/25/2018||Thomas M Kent||Director||Buy||1,100||$24.19||$26,609.00||1,100|| |
|1/6/2016||Timothy L Gasperoni||SVP||Buy||862||$28.98||$24,980.76||862|| |
Tekla Healthcare Investors (NYSE HQH) News Headlines
Tekla Healthcare Investors (NYSE:HQH) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Tekla Healthcare Investors (NYSE:HQH) Income Statement, Balance Sheet and Cash Flow Statement
Tekla Healthcare Investors (NYSE HQH) Stock Chart for Thursday, March, 22, 2018